GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Research & Development

Chordia Therapeutics (TSE:190A) Research & Development : 円0.00 Mil (TTM As of Feb. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Chordia Therapeutics's Research & Development for the three months ended in Feb. 2025 was 円0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2025 was 円0.00 Mil.


Chordia Therapeutics Research & Development Historical Data

The historical data trend for Chordia Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Research & Development Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Research & Development
1,322.95 1,656.11 - -

Chordia Therapeutics Quarterly Data
Aug21 Aug22 May23 Aug23 May24 Aug24 Feb25
Research & Development Get a 7-Day Free Trial - - - - -

Chordia Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordia Therapeutics  (TSE:190A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Chordia Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines